IL190289A0 - Method for obtaining human smooth muscular cells and uses thereof - Google Patents

Method for obtaining human smooth muscular cells and uses thereof

Info

Publication number
IL190289A0
IL190289A0 IL190289A IL19028908A IL190289A0 IL 190289 A0 IL190289 A0 IL 190289A0 IL 190289 A IL190289 A IL 190289A IL 19028908 A IL19028908 A IL 19028908A IL 190289 A0 IL190289 A0 IL 190289A0
Authority
IL
Israel
Prior art keywords
cells
smooth muscular
muscular cells
concerns
muscular
Prior art date
Application number
IL190289A
Other languages
English (en)
Original Assignee
Assist Publ Hopitaux De Paris
Inst Vaisseaux Et Du Sang Of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assist Publ Hopitaux De Paris, Inst Vaisseaux Et Du Sang Of filed Critical Assist Publ Hopitaux De Paris
Publication of IL190289A0 publication Critical patent/IL190289A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0661—Smooth muscle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/165—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1323—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from skeletal muscle cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Excavating Of Shafts Or Tunnels (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL190289A 2005-09-19 2008-03-19 Method for obtaining human smooth muscular cells and uses thereof IL190289A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0509557A FR2890977A1 (fr) 2005-09-19 2005-09-19 Procede d'obtention de cellules musculaires lisses humaines et leurs applications
PCT/FR2006/002144 WO2007034069A1 (fr) 2005-09-19 2006-09-19 Procede d'obtention de cellules musculaires lisses humaines et leurs applications

Publications (1)

Publication Number Publication Date
IL190289A0 true IL190289A0 (en) 2011-08-01

Family

ID=36587333

Family Applications (1)

Application Number Title Priority Date Filing Date
IL190289A IL190289A0 (en) 2005-09-19 2008-03-19 Method for obtaining human smooth muscular cells and uses thereof

Country Status (10)

Country Link
US (1) US20090269310A1 (cg-RX-API-DMAC7.html)
EP (1) EP1934333B9 (cg-RX-API-DMAC7.html)
JP (1) JP2009508511A (cg-RX-API-DMAC7.html)
CN (1) CN101310013B (cg-RX-API-DMAC7.html)
AT (1) ATE531791T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006293814B2 (cg-RX-API-DMAC7.html)
CA (1) CA2622916A1 (cg-RX-API-DMAC7.html)
FR (1) FR2890977A1 (cg-RX-API-DMAC7.html)
IL (1) IL190289A0 (cg-RX-API-DMAC7.html)
WO (1) WO2007034069A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2909559B1 (fr) * 2006-12-06 2012-09-07 Inst Vaisseaux Et Du Sang Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation
KR20180122484A (ko) 2008-11-04 2018-11-12 인리젠 세포-지지체 구조물
WO2019115790A1 (en) * 2017-12-14 2019-06-20 Innovacell Biotechnologie Ag Methods for obtaining muscle derived cells
CN112119155A (zh) * 2018-05-08 2020-12-22 苏黎士大学 用于无异种产生hMPC群的方法
EP3942020B1 (en) * 2019-03-22 2024-05-15 Innovacell GmbH Methods for obtaining induced smooth muscle cells
JPWO2024143453A1 (cg-RX-API-DMAC7.html) * 2022-12-28 2024-07-04

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2810045B1 (fr) * 2000-06-07 2004-09-03 Assist Publ Hopitaux De Paris Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations
US20040247575A1 (en) * 2003-06-03 2004-12-09 Caplice Noel M. Smooth muscle progenitor cells

Also Published As

Publication number Publication date
AU2006293814B2 (en) 2011-09-29
JP2009508511A (ja) 2009-03-05
CN101310013B (zh) 2011-09-07
EP1934333B9 (fr) 2012-05-02
US20090269310A1 (en) 2009-10-29
CA2622916A1 (fr) 2007-03-29
EP1934333A1 (fr) 2008-06-25
EP1934333B1 (fr) 2011-11-02
CN101310013A (zh) 2008-11-19
AU2006293814A1 (en) 2007-03-29
FR2890977A1 (fr) 2007-03-23
WO2007034069A1 (fr) 2007-03-29
ATE531791T1 (de) 2011-11-15

Similar Documents

Publication Publication Date Title
IL190289A0 (en) Method for obtaining human smooth muscular cells and uses thereof
EP2298862A3 (en) Mesenchymal stem cells and uses therefor
WO2004009767A3 (en) Cell therapy for regeneration
EP2172549A3 (en) RNAi expression constructs
PT1404811E (pt) O monóxido de carbono melhora os resultados nos transplantes de tecidos e de orgãos e suprime a apoptose
EA200600076A1 (ru) Композиции и способы увеличения активности теломеразы
WO2004047747A3 (en) Compositions and methods for cell dedifferentiation and tissue regeneration
EP2465921A3 (en) Cardiac stem cells from biopsy
CL2004000639A1 (es) Compuestos derivados de quinolina y quinoxalina, composicion farmaceutica, combinacion farmaceutica; kit farmaceutico; y su uso para tratar aterosclerosis, enfermedad de arteria coronaria, enfermedad cardiaca coronaria, enfermedad vascular coronaria,
EP3502256A3 (en) Recombinant vectors
WO2008008770A3 (en) 6, 9-disubstituted purine derivatives and their use for treating skin
WO2005018549A3 (en) Methods and compositions for tissue repair
WO2008003656A3 (en) Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics
WO2006081435A3 (en) Method of providing readily available cellular material derived from cord blood, and a composition thereof
WO2006093857A3 (en) Method of providing readily available cellular material derived from peripheral blood and a composition thereof
WO2008066886A3 (en) Muscle derived cells for the treatment of cardiac pathologies and methods of making and using the same
EP2319531A3 (en) Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
EP1599128A4 (en) METHOD FOR THE TREATMENT OF ILLNESSES THROUGH TRANSPLANTATION OF DEVELOPING ALLOGENIC OR XENOGENIC ORGANS OR WOVEN FABRICS
WO2007016529A3 (en) Methods for screening compounds for proarrhythmic risk and antiarrhythmic efficacy
WO2006093860A3 (en) Method and composition for repairing heart tissue
WO2007070725A3 (en) Device producing and use of microwave energy for thermotherapy
SI1596879T1 (sl) Uporaba spojine kahalalida za pripravo zdravila za zdravljenje luskavice
GB2419186C (en) Method to measure the effect of topically applied agents using skin maintained in organ culture.
WO2005007093A3 (en) Uses of il-12 in hematopoiesis
EP2287301A3 (en) Methods and compositions to inhibit P2X7 receptor expression